Dermatology
Alopecia (Areata + Scarring)
Distinguish patterns (alopecia areata, androgenetic, telogen effluvium, scarring), exclude reversible causes, biologics for severe AA.
Source: BAD; British Hair + Nail Society
Step 1 of ~5
question
Pattern Recognition
Different conditions, different management.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Baricitinib 2–4mg (Atopic Dermatitis / Alopecia Areata) · JAK inhibitor (JAK1/JAK2) — systemic immunosuppressant
- Tezepelumab (CRSwNP / Severe Asthma) · Anti-TSLP (Thymic Stromal Lymphopoietin) Monoclonal Antibody
- Quinine · Antimalarial — Severe / Complicated Malaria (IV) / Nocturnal Cramps (Oral)
- Pyridostigmine bromide · Reversible cholinesterase inhibitor
- Intra-uterine contraceptive device (copper) · Long-acting reversible contraception (Cu-IUD)
- Amphotericin B (Ophthalmic — Severe Fungal Keratitis/Endophthalmitis) · Antifungal — Polyene (Ophthalmic Compounded / Systemic IV)
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD
Decision support only. Always apply local guidelines and clinical judgement.